痰热清在危重患者中的应用

目的：探讨痰热清在危重患者中的临床效果。方法54例慢性阻塞性肺疾病（简称慢阻肺）急性加重应用呼吸机的患者随机分成对照组和实验组,对照组29例,常规应用抗生素、解痉药、化痰药及脏器保护、营养药物。实验组25例,在原有治疗的基础上加用痰热清注射液20 ml,2次/d。对比两组治疗效果。结果实验组机械通气平均应用天数、抗生素平均应用天数与对照组比较差异有统计学意义（P＜0.05）。平均住院天数两组比较差异无统计学意义（P〈0.05）。结论痰热清可用于慢阻肺急性加重的辅助治疗,可减少机械通气及抗生素的应用时间,预防或减少抗生素的耐药性,降低患者的医疗费用。

Application of Tanreqing in critical patients

Objective To explore the clinical effect of Tanreqing in critical patients. Methods A total of 54 cases with chronic obstructive pulmonary disease, who were at acute exacerbation and using breathing machine, were randomly divided into control group and experimental group. The control group with 29 cases received conventional use of antibiotics, spasmolysis medicine, expectorant, and nutritious organs protection medicine. The experimental group with 25 cases received additional 20 ml of Tanreqing injection for 2 times/d. The curative effects of the two groups were compared. Results There were statistically significant differences of average mechanical ventilation time and average antibiotics application time between the two groups （P〈0.05）. The average hospital stays of the two groups had no statistically significant difference between the two groups （P〉0.05）. Conclusion The application of Tanreqing in the adjuvant treatment of chronic obstructive pulmonary disease can reduce the application times of mechanical ventilation and antibiotics. Meanwhile it can prevent or decrease drug resistance of antibiotics, and lower medical costs.